Zu "882663-88-9" wurden 3 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
AMG-47a
Artikelnummer: TGM-T7123-100mg
Description: AMG-47a is a potent inhibitor of Lck and T cell proliferation. AMG-47a could promote the degradation of the KRAS oncoprotein. AMG-47a selectively reduced the levels of EGFP-KRASG12V protein but did not affect EGFP protein in cells. Target: JAK, VEGFR, p38 MAPK, Src. Smiles:...
| Anwendung: | Lck/VEGFR2/p38alpha/JAK3 inhibitor |
| CAS | 882663-88-9 |
| MW: | 535.56 D |
ab 40,00 €
AMG-47a
Artikelnummer: SYN-1007-M001
Soluble in DMSO. The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells. Genetic evidence in both mice and humans demonstrates that Lck kinase activity is critical for signaling mediated by the T cell receptor (TCR), which leads to...
| Schlagworte: | AMG47a |
| Anwendung: | Lck inhibitor |
| CAS | 882663-88-9 |
| MW: | 535,6 D |
ab 300,00 €
AMG 47a
Artikelnummer: Cay25339-10
AMG 47a is an orally bioavailable inhibitor of Lck, VEGF receptor 2 (VEGFR2/KDR), p38alpha, and JAK3 (IC50s = 0.2, 1, 3, and 72 nM, respectively). It is selective for these kinases over a panel of additional kinases including SYK, JNK1, and PKAbeta (IC50s = 292 to >25,000 nM) but does inhibit Src (IC50 = 2 nM). It...
| Schlagworte: | 4-methyl-3-[2-[[2-(4-morpholinyl)ethyl]amino]-6-quinazolinyl]-N-[3-(trifluoromethyl)phenyl]-benzamide |
| Anwendung: | Lck/VEGFR2/p38alpha/JAK3 inhibitor |
| CAS | 882663-88-9 |
| MW: | 535.6 D |
ab 166,00 €
